Truist Financial Corp (NYSE:TFC) reported mixed results for Q1 2026, exceeding EPS estimates with $1.09 against a $1.0046 forecast, but missing revenue expectations by posting $5.152 billion against a $5.222 billion forecast. This led to a negative pre-market reaction, with shares down approximately 0.77%, as investors appear to be focusing on the revenue shortfall despite the earnings beat. The company did not provide forward-looking guidance, leaving future performance to be benchmarked against existing analyst estimates.

This report analyzes eBay's marketplace model, its core business, and its competitive position in the e-commerce sector, particularly for U.S. and English-speaking investors. It examines the company's revenue streams from auctions and fixed-price listings, its key product categories like collectibles and auto parts, and how it competes with larger rivals like Amazon. The article concludes by discussing analyst views, potential risks, and what investors should monitor in eBay's financial performance and strategic moves.

Walmart plans to renovate dozens of its stores across Maryland and Virginia. These renovations will include expanded pharmacy delivery services, updated store layouts, and the introduction of new technologies. This initiative aims to enhance the shopping experience for customers in these regions.

This article analyzes Kimberly-Clark Corp (K) stock, highlighting its defensive qualities and dividend reliability for investors amidst volatile markets. The company's essential brands like Huggies and Kleenex provide stable demand and predictable revenue, supporting its long track record of increasing dividends. It also discusses the company's strategic focus, financial health, and resilience against economic pressures, making it an attractive option for income-focused and stability-seeking investors.

Allegiant Travel (ALGT) has experienced a significant 90.8% surge over the past year, prompting an evaluation of its current valuation. Despite recent mixed performance, Discounted Cash Flow (DCF) analysis suggests the stock is substantially undervalued at $84.24, with an estimated intrinsic value of $457.79 per share. The Price-to-Sales (P/S) ratio also indicates potential undervaluation, trading below Simply Wall St’s proprietary Fair Ratio.

Gilead Sciences, Inc. announced that it has received all necessary regulatory approvals for its acquisition of Arcellx, including decisions from the Australian and Austrian competition authorities. Consequently, Gilead has extended its tender offer for all outstanding shares of Arcellx common stock to April 27, 2026. As of April 16, 2026, approximately 17.5% of Arcellx's shares have been tendered, with the offer price set at $115.00 per share cash plus contingent value rights.

Cardinal Health Inc. is positioned for stable growth in the U.S. healthcare sector due to its essential role in drug and medical product distribution, which benefits from rising healthcare spending and an aging population. The company's focus on efficient logistics and a diversified product portfolio, including pharmaceuticals and medical supplies, provides resilient demand that is less susceptible to economic fluctuations. While facing competition and regulatory pressures, Cardinal Health's market leadership and strategic investments aim to ensure consistent performance for investors.

This article highlights five significant analyst upgrades for various companies on Friday. Notably, a Mizuho analyst upgraded Texas Instruments from Underperform to Neutral, increasing the price target. Other companies receiving upgrades include Postal Realty Trust Inc., Onto Innovation Inc., Petroleo Brasileiro ADR, and Quaker Chemical Corp.

ZestyAI, an AI-driven insurance risk analytics provider, has announced that Scott Stephenson, former Chairman, President, and CEO of Verisk Analytics, has joined its Board of Directors. Stephenson's appointment comes as the insurance industry transitions further into integrating artificial intelligence into decision-making. Both Stephenson and ZestyAI's CEO, Attila Toth, emphasize the importance of AI and proprietary data in shaping the future of risk understanding and management in the industry.

Faruqi & Faruqi, LLP is reminding Gartner (NYSE: IT) investors of the May 18, 2026 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges that Gartner made false and/or misleading statements regarding its growth rates and ability to meet consulting revenue targets and CV growth rates. This follows a significant drop in Gartner's stock price after the company reported Q4 2025 financial results and a disappointing 2026 outlook.